T-cell type acute leukaemia and Ards (acute respiratory distress syndrome)

Summary:

Ards (acute respiratory distress syndrome) is found among people with T-cell type acute leukaemia, especially for people who are female, 10-19 old.

The study analyzes which people have Ards (acute respiratory distress syndrome) with T-cell type acute leukaemia. It is created by eHealthMe based on reports of 15 people who have T-cell type acute leukaemia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is T-cell type acute leukaemia?

T-cell type acute leukaemia (a form of cancer of the white blood cells) is found to be associated with 22 drugs and 100 conditions by eHealthMe. Check the latest studies of T-cell type acute leukaemia.

What is Ards (acute respiratory distress syndrome)?

Ards (acute respiratory distress syndrome) (sudden failure of the respiratory (breathing) system) is found to be associated with 1,237 drugs and 2,606 conditions by eHealthMe. Check the latest studies of Ards (acute respiratory distress syndrome).

On Jul, 19, 2026

15 people who have T-Cell Type Acute Leukaemia and Ards (Acute Respiratory Distress Syndrome) are studied.

Would you have Ards (acute respiratory distress syndrome) when you have T-cell type acute leukaemia?

Gender of people who have T-Cell Type Acute Leukaemia and experienced Ards (Acute Respiratory Distress Syndrome) *:

female: 84.62 %
male: 15.38 %

Age of people who have T-Cell Type Acute Leukaemia and experienced Ards (Acute Respiratory Distress Syndrome) *:

Common co-existing conditions for these people *:

Neoplasm Malignant (cancer tumour): 2 people, 13.33%
High Blood Pressure: 2 people, 13.33%

Common drugs taken by these people *:

Nelarabine: 10 people, 66.67%
Cyclophosphamide: 9 people, 60.00%
Vancomycin: 9 people, 60.00%
Mercaptopurine: 8 people, 53.33%
Lansoprazole: 8 people, 53.33%
Cytarabine: 8 people, 53.33%
Nystatin: 8 people, 53.33%
Methotrexate: 8 people, 53.33%
Voriconazole: 8 people, 53.33%
Piperacillin And Tazobactam: 7 people, 46.67%

Common symptoms for these people *:

Depressed Level Of Consciousness: 9 people, 60.00%
Sinus Tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node): 9 people, 60.00%
Nosebleed (bleeding from nose): 9 people, 60.00%
Blood Bilirubin Increased: 8 people, 53.33%
Diarrhea: 7 people, 46.67%
Swallowing Difficulty: 7 people, 46.67%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 7 people, 46.67%
Peripheral Motor Neuropathy (muscles in the body become progressively weaker over months to years): 6 people, 40.00%
Caecitis (inflammation of the cecum): 6 people, 40.00%
Eating Disorder: 5 people, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Ards (acute respiratory distress syndrome)?

- Check whether Ards (acute respiratory distress syndrome) is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

T-cell type acute leukaemia (1,849 reports)
Ards (acute respiratory distress syndrome) (26,108 reports)

All the drugs that are associated with Ards (acute respiratory distress syndrome):

Ards (acute respiratory distress syndrome) (1,237 drugs)

All the conditions that are associated with Ards (acute respiratory distress syndrome):

Ards (acute respiratory distress syndrome) (2,606 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Ards (acute respiratory distress syndrome) and T-cell type acute leukaemia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.